SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-017196
Filing Date
2006-03-16
Accepted
2006-03-16 12:30:13
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-2021_110k.htm 10-K 1395747
2 INSTRUMENTS DEFINING THE RIGHTS OF SECURITY HOLDERS, INCLUDING INDENTURES a06-2021_1ex4d7.htm EX-4.7 100338
3 MATERIAL CONTRACTS a06-2021_1ex10d49.htm EX-10.49 69102
4 CONSENTS OF EXPERTS AND COUNSEL a06-2021_1ex23d0.htm EX-23.0 5088
5 302 CERTIFICATION a06-2021_1ex31d1.htm EX-31.1 14866
6 302 CERTIFICATION a06-2021_1ex31d2.htm EX-31.2 14958
7 906 CERTIFICATION a06-2021_1ex32d0.htm EX-32.0 7840
  Complete submission text file 0001104659-06-017196.txt   1609444
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14895 | Film No.: 06690769
SIC: 2834 Pharmaceutical Preparations